Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.
VISTA HealthPlan is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
ReproTech is a company that specializes in long term cryostorage for fertility preservation through their nationwide network of partner Freezing Centers.
Form Health helps people lose weight in a medically supervised environment.
Hartford Neurology is a Bloomfield, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.